BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 26058897)

  • 1. TrxR1 as a potent regulator of the Nrf2-Keap1 response system.
    Cebula M; Schmidt EE; Arnér ES
    Antioxid Redox Signal; 2015 Oct; 23(10):823-53. PubMed ID: 26058897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between cytosolic disulfide reductase systems and the Nrf2/Keap1 pathway.
    Schmidt EE
    Biochem Soc Trans; 2015 Aug; 43(4):632-8. PubMed ID: 26551704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells.
    Sun S; Zhang Y; Xu W; Yang R; Yang Y; Guo J; Ma Q; Ma K; Zhang J; Xu J
    Biomed Pharmacother; 2022 Feb; 146():112546. PubMed ID: 34954641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioredoxin reductase 1 inhibitor shikonin promotes cell necroptosis via SecTRAPs generation and oxygen-coupled redox cycling.
    Zhang Y; Sun S; Xu W; Yang R; Yang Y; Guo J; Ma K; Xu J
    Free Radic Biol Med; 2022 Feb; 180():52-62. PubMed ID: 34973363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory nitrosylation of mammalian thioredoxin reductase 1: Molecular characterization and evidence for its functional role in cellular nitroso-redox imbalance.
    Engelman R; Ziv T; Arnér ESJ; Benhar M
    Free Radic Biol Med; 2016 Aug; 97():375-385. PubMed ID: 27377780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selenium in the redox regulation of the Nrf2 and the Wnt pathway.
    Brigelius-Flohé R; Kipp AP
    Methods Enzymol; 2013; 527():65-86. PubMed ID: 23830626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine.
    Anestål K; Arnér ES
    J Biol Chem; 2003 May; 278(18):15966-72. PubMed ID: 12574159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2.
    Sakurai A; Nishimoto M; Himeno S; Imura N; Tsujimoto M; Kunimoto M; Hara S
    J Cell Physiol; 2005 Jun; 203(3):529-37. PubMed ID: 15521073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of the Keap1-Nrf2 system.
    Suzuki T; Yamamoto M
    Free Radic Biol Med; 2015 Nov; 88(Pt B):93-100. PubMed ID: 26117331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity.
    Dodson M; Redmann M; Rajasekaran NS; Darley-Usmar V; Zhang J
    Biochem J; 2015 Aug; 469(3):347-55. PubMed ID: 26205490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
    Uruno A; Motohashi H
    Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease.
    Tebay LE; Robertson H; Durant ST; Vitale SR; Penning TM; Dinkova-Kostova AT; Hayes JD
    Free Radic Biol Med; 2015 Nov; 88(Pt B):108-146. PubMed ID: 26122708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioredoxin Reductase Inhibition for Cancer Therapy.
    Gencheva R; Arnér ESJ
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():177-196. PubMed ID: 34449246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2: friend and foe in preventing cigarette smoking-dependent lung disease.
    Müller T; Hengstermann A
    Chem Res Toxicol; 2012 Sep; 25(9):1805-24. PubMed ID: 22686525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin reductase 1 and NADPH directly protect protein tyrosine phosphatase 1B from inactivation during H
    Dagnell M; Pace PE; Cheng Q; Frijhoff J; Östman A; Arnér ESJ; Hampton MB; Winterbourn CC
    J Biol Chem; 2017 Sep; 292(35):14371-14380. PubMed ID: 28684416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Keap1-Nrf2 system and diabetes mellitus.
    Uruno A; Yagishita Y; Yamamoto M
    Arch Biochem Biophys; 2015 Jan; 566():76-84. PubMed ID: 25528168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
    Itoh K; Mimura J; Yamamoto M
    Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the Nrf2/Keap1/ARE signaling system.
    Tkachev VO; Menshchikova EB; Zenkov NK
    Biochemistry (Mosc); 2011 Apr; 76(4):407-22. PubMed ID: 21585316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Details in the catalytic mechanism of mammalian thioredoxin reductase 1 revealed using point mutations and juglone-coupled enzyme activities.
    Xu J; Cheng Q; Arnér ES
    Free Radic Biol Med; 2016 May; 94():110-20. PubMed ID: 26898501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals.
    Surh YJ; Kundu JK; Na HK
    Planta Med; 2008 Oct; 74(13):1526-39. PubMed ID: 18937164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.